THE TOP 10 - China, India set to keep pharma firms in fine health
The pharmaceuticals sector in Asia is dominated by Chinese and Indian companies, reflecting the potential of markets with huge populations, growing wealth and increasing access to medical care. Chris Wright finds out how drugs and demographics mix as he measures out the sector's top 10 regional companies in terms of return on equity.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts